The global pharmaceutical market is witnessing an unprecedented surge in demand for hematinic agents. Iron Deficiency Anemia (IDA) remains the most prevalent nutritional disorder worldwide, affecting over 1.6 billion people. Within this landscape, the combination of Folic Acid and Ferrous Sulphate stands as the gold standard for therapeutic intervention, particularly in maternal health and geriatric care.
Jiangxi Serum Pharma Industries Co., Ltd. addresses this gap by integrating advanced bioavailability research with large-scale manufacturing capacity, ensuring that our Folic Acid Ferrous Sulphate Tablets exceed BP/USP standards.
Strategic procurement of high-purity raw materials ensures consistent potency and minimal heavy metal contamination, meeting stringent EU and FDA entry requirements.
Utilizing proprietary co-crystallization and micro-encapsulation techniques to reduce gastric irritation commonly associated with ferrous salts.
Operating under strict GMP guidelines since 2017, with a focus on biological stability and shelf-life optimization for tropical and humid climates.
Jiangxi Serum Pharma Industries Co., Ltd. is a professional supplier of pharmaceutical and nutritional products in China. For nearly 10 years, we have been dedicated to exporting biological products, vaccines, Western medicines, raw materials, intermediates, medical consumables, food additives, and plant extracts, and have accumulated rich industry experience.
Our commitment to E-E-A-T (Experience, Expertise, Authoritativeness, and Trustworthiness) is reflected in our rigorous quality control audits and our ability to navigate complex international regulatory landscapes. We don't just supply products; we provide "Regulatory Peace of Mind."
Serum Pharma will continuously monitor the development of the cutting-edge markets. Currently, we have already cooperated with our partners on the customization of Pre-Mix, Co-Crystallization and Bio-Fermentation products service.
Advanced Pre-MixStable homogenization of Folic Acid and Iron carriers to prevent ingredient segregation during high-speed tableting processes.
Co-CrystallizationA molecular-level engineering approach to enhance the solubility and absorption rate of Ferrous Sulphate while masking the metallic aftertaste.
Bio-FermentationDeveloping plant-based, fermented iron sources for the growing "clean label" and vegan pharmaceutical market segment.
We understand that "One size does not fit all." Localization is key to global health equity. Jiangxi Serum Pharma provides:
April 24, 2026 - Exploring the transition to plant-derived squalene in pharmaceutical emulsions...
April 17, 2026 - A deep dive into the molecule's role in modern anti-inflammatory protocols...
Breakthrough! Lilly's oral small-molecule GLP1 weight-loss drug approved with 50-day rapid process...
Learn More »